From: A simulation model of colorectal cancer surveillance and recurrence
Variable | Input parameter estimate | Range for sensitivity analysis | Sourcea |
---|---|---|---|
Screening test performance | |||
Carcinoembryonic Antigen test (CEA) | |||
Sensitivity | .64 | .49 - .79 | [41] |
Specificity | .90 | .75 – 1.00 | [41] |
Chest X ray | |||
Sensitivity | .76 | .61 - .91 | |
Specificity | .95 | .80 – 1.00 | [43] |
CT – Hepatic metastases | |||
Sensitivity | .83 | .68 - .98 | |
Specificity | .93 | .78 – 1.00 | |
CT – Other abdominal metastases | |||
Sensitivity | .46 | .31 - .61 | [44] |
Specificity | .98 | .83 – 1.00 | [44] |
Hepatic ultrasound | |||
Sensitivity | .62 | .47 - .77 | |
Specificity | .85 | .70 – 1.00 | |
Colonoscopy | |||
Sensitivity | .95 | .80 – 1.00 | |
Specificity | 1.00 | .85 – 1.00 | |
Clinical interview/examination b | |||
Sensitivity | .42 | .27 - .57 | [5] |
Specificity | .95 | .70 – 1.00 | [5] |
Life expectancy | |||
After initial surgery, given no recurrence | 20.7Â years | --c | [51] |
After recurrence with curative salvage | 21 months | 15 – 27 | [52]d |
After diagnosis of unresectable recurrence | 8 months | 4 – 12 | [53]e |